375 related articles for article (PubMed ID: 28777652)
21. Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.
Goense L; Heethuis SE; van Rossum PSN; Voncken FEM; Lagendijk JJW; Lam MGEH; Terhaard CH; van Hillegersberg R; Ruurda JP; Mook S; van Lier ALHMW; Lin SH; Meijer GJ
Nucl Med Commun; 2018 Jan; 39(1):60-67. PubMed ID: 29023336
[TBL] [Abstract][Full Text] [Related]
22. Current generation time-of-flight (18)F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands.
Koopman D; van Dalen JA; Stigt JA; Slump CH; Knollema S; Jager PL
Ann Nucl Med; 2016 Feb; 30(2):145-52. PubMed ID: 26644009
[TBL] [Abstract][Full Text] [Related]
23. Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study.
Jena A; Taneja S; Goel R; Renjen P; Negi P
Eur J Radiol; 2014 Jul; 83(7):1269-1274. PubMed ID: 24813529
[TBL] [Abstract][Full Text] [Related]
24. Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.
Keramida G; Dunford A; Siddique M; Cook GJ; Peters AM
Eur J Radiol; 2016 May; 85(5):1012-5. PubMed ID: 27130064
[TBL] [Abstract][Full Text] [Related]
25. 18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC).
Bernstine H; Domachevsky L; Nidam M; Goldberg N; Abadi-Korek I; Shpilberg O; Groshar D
Medicine (Baltimore); 2018 Apr; 97(16):e0490. PubMed ID: 29668631
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear cause.
Rauscher I; Beer AJ; Schaeffeler C; Souvatzoglou M; Crönlein M; Kirchhoff C; Sandmann G; Fürst S; Kilger R; Herz M; Ziegler S; Schwaiger M; Eiber M
J Nucl Med; 2015 Mar; 56(3):430-5. PubMed ID: 25678485
[TBL] [Abstract][Full Text] [Related]
27. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT.
Wetter A; Lipponer C; Nensa F; Heusch P; Rübben H; Altenbernd JC; Schlosser T; Bockisch A; Pöppel T; Lauenstein T; Nagarajah J
Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):79-88. PubMed ID: 24085502
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer.
Brandmaier P; Purz S; Bremicker K; Höckel M; Barthel H; Kluge R; Kahn T; Sabri O; Stumpp P
PLoS One; 2015; 10(11):e0141684. PubMed ID: 26551527
[TBL] [Abstract][Full Text] [Related]
30. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G
Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
[TBL] [Abstract][Full Text] [Related]
31. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.
Pujara AC; Raad RA; Ponzo F; Wassong C; Babb JS; Moy L; Melsaether AN
Breast J; 2016 May; 22(3):264-73. PubMed ID: 26843433
[TBL] [Abstract][Full Text] [Related]
32. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
Akamatsu G; Mitsumoto K; Taniguchi T; Tsutsui Y; Baba S; Sasaki M
Eur J Radiol; 2014 Jan; 83(1):226-30. PubMed ID: 24144448
[TBL] [Abstract][Full Text] [Related]
33. 18F-fluoroethylcholine (18F-Cho) PET/MRI functional parameters in pediatric astrocytic brain tumors.
Fraioli F; Shankar A; Hargrave D; Hyare H; Gaze MN; Groves AM; Alongi P; Stoneham S; Michopoulou S; Syed R; Bomanji JB
Clin Nucl Med; 2015 Jan; 40(1):e40-5. PubMed ID: 25188640
[TBL] [Abstract][Full Text] [Related]
34. Comparison of brain F-18 FDG PET/MRI with PET/CT imaging in pediatric patients.
Sager G; Akgun E; Abuqbeitah M; Uslu L; Asa S; Akgun MY; Beytur F; Baydili KN; Sager S
Clin Neurol Neurosurg; 2021 Jul; 206():106669. PubMed ID: 33984753
[TBL] [Abstract][Full Text] [Related]
35. Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
Rasmussen JH; Fischer BM; Aznar MC; Hansen AE; Vogelius IR; Löfgren J; Andersen FL; Loft A; Kjaer A; Højgaard L; Specht L
Br J Radiol; 2015 Apr; 88(1048):20140655. PubMed ID: 25634069
[TBL] [Abstract][Full Text] [Related]
36. Quantitative and Visual Assessments toward Potential Sub-mSv or Ultrafast FDG PET Using High-Sensitivity TOF PET in PET/MRI.
Behr SC; Bahroos E; Hawkins RA; Nardo L; Ravanfar V; Capbarat EV; Seo Y
Mol Imaging Biol; 2018 Jun; 20(3):492-500. PubMed ID: 29192363
[TBL] [Abstract][Full Text] [Related]
37. Changes of [
Liu Y; Gao MJ; Zhou J; Du F; Chen L; Huang ZK; Hu JB; Lou C
BMC Med Imaging; 2021 Sep; 21(1):133. PubMed ID: 34530768
[TBL] [Abstract][Full Text] [Related]
38. Value of
Alobthani G; Romanov V; Isohashi K; Matsunaga K; Watabe T; Kato H; Tatsumi M; Shimosegawa E; Hatazawa J
Hell J Nucl Med; 2018; 21(1):7-14. PubMed ID: 29550841
[TBL] [Abstract][Full Text] [Related]
39. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
Sun W; Xu J; Hu W; Zhang Z; Shen W
Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167
[TBL] [Abstract][Full Text] [Related]
40. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]